Stock comparison
Natera, Inc. is 8.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($40.37 B vs $4.99 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NTRA is larger
Natera, Inc. is 8.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($40.37 B vs $4.99 B).
Market value leader
NTRA
Natera, Inc. is 8.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($40.37 B vs $4.99 B).
Revenue leader
NTRA
CAI: $812.03M vs NTRA: $2.31B.
Profit leader
CAI
CAI: -$68.09M vs NTRA: -$208.16M.
Margin leader
CAI
CAI: -8.4% vs NTRA: -9.0% net margin.
| Metric | CAI | NTRA |
|---|---|---|
| Market cap | $4.99 B | $40.37 B |
| US-listed rank | #1419 | #386 |
| Revenue (latest FY) | $812.03M | $2.31B |
| Net income (latest FY) | -$68.09M | -$208.16M |
| Net margin | -8.4% | -9.0% |
| P/E (trailing FY) | - | - |
| SEC filings | 102 | 1,695 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Natera, Inc. is 8.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($40.37 B vs $4.99 B).
In their latest fiscal years, Caris Life Sciences, Inc. reported $812.03M in revenue while Natera, Inc. reported $2.31B.
Full pages: Caris Life Sciences, Inc. and Natera, Inc., or browse the full rankings.